Advanced Proteome Therapeutics Corporation (APTCF) 是一家上市公司 屬於 醫療保健 板塊，經營於 生物科技 產業. 公司總部位於 Burnaby, BC, 加拿大. 現任CEO為 Benjamin Krantz.
APTCF 擁有 IPO日期為 2009-07-10, 在 Other OTC, 市值為 $149.63K.
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
